Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia-Reference-Cited by-同舟云学术

Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia

Published:2016-03-08 Issue:7 Volume:30 Page:1562-1567
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Gunnarsson N,Höglund M,Stenke L,Wållberg-Jonsson S,Sandin F,Björkholm M,Dreimane A,Lambe M,Markevärn B,Olsson-Strömberg U,Wadenvik H,Richter J,Själander A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201659.pdf

Reference33 articles.

1. Björkholm M, Ohm L, Eloranta S, Derolf A, Hultcrantz M, Sjöberg J et al. Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008. J Clin Oncol 2011; 29: 2514–2520.

2. Höglund M, Sandin F, Hellström K, Björeman M, Björkholm M, Brune M et al. Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry. Blood 2013; 122: 1284–1292.

3. Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K et al. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001. Radiat Res 2013; 179: 361–382.

4. Gunnarsson N, Stenke L, Hoglund M, Sandin F, Bjorkholm M, Dreimane A et al. Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era. Br J Haematol 2015; 169: 683–688.

5. Johnson KJ, Blair CM, Fink JM, Cerhan JR, Roesler MA, Hirsch BA et al. Medical conditions and risk of adult myeloid leukemia. Cancer Causes Control 2012; 23: 1083–1089.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Rare Case of Dual Metachronous Primary Malignancies, Chronic Myeloid Leukemia, and Tongue Carcinoma in a Patient With Long-Standing Systemic Lupus Erythematosus: A Case Report and Review of Literature;Cureus;2024-03-21

2. Hematologic complications after kidney and pancreas transplant in a patient with chronic myeloid leukemia;Cleveland Clinic Journal of Medicine;2024-03

3. Features of immune mediated diseases in JAK2 (V617F)-positive myeloproliferative neoplasms and the potential therapeutic role of JAK inhibitors;European Journal of Internal Medicine;2023-12

4. Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia;International Journal of Hematology;2022-11-14

5. Cross-Domain Text Mining to Predict Adverse Events from Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia;Cancers;2022-09-26